Bioprocess Intensification Using N-1 Perfusion Technology
Explore bioprocess intensification using N-1 perfusion to boost bioreactor efficiency, volumetric productivity, and fed-batch performance for mAbs. Read for more.
Future-Ready QC Labs in Pharma 4.0: How Automation, Biometrics, and VR Are Redefining Quality Standards in India
See how pharma 4.0 is reshaping QC labs in India through automation, biometrics, and VR for stronger digital quality control. Read more.
Discovery Development Manufacturing
Syngene offers integrated discovery biology services across multiple modalities, from target validation to translational sciences, enabling faster and more informed therapeutic decisions.
Your Integrated Bioanalytical Partner for Translational and Clinical Success
Syngene, with its integrated bioanalytical capabilities across small and large molecules, delivers accurate, regulatory‑compliant data to support programs from discovery through clinical development.
Built-for-purpose Biomarker Solutions Enhancing Speed, Precision, and Confidence
Syngene, with its comprehensive biomarker services spanning discovery, validation, and context‑of‑use assays, enables early decision‑making, patient stratification, and precision‑led drug development.
Next-Gen Modalities, Expertly Enabled
Syngene’s integrated capabilities in Oligonucleotides, Peptides, & Conjugates. From discovery to GMP, we partner with you to accelerate novel modalities.
CPHI Japan 2026 Takeaways: Why supply chain diversification is redefining CDMO trust in Japan
Explore how supply chain diversification is changing CDMO selection in Japan, from technical depth to global operating models. Read more.
Integrated gene to GMP services with mAb accelerator
Integrated gene to GMP services with mAb accelerator – Get a 4‑month head start with Syngene’s mAb Accelerator Program, designed to fast‑track biopharma success through early investment, risk sharing, and flexible commercial models.
Decoding the FDA’s AMT program through process analytical technology
Learn how process analytical technology enables advanced manufacturing technologies under the FDA AMT program and transforms pharma production. Explore the insights today.
Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
Publication: Fierce Pharma